Safety Study of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Treat Relapsed EBV-Positive Lymphoma, - No Study Results Posted

Safety Study of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Treat Relapsed EBV-Positive Lymphoma, (ANGEL)

This study is ongoing, but not recruiting participants.

Study NCT00058617 Information provided by Baylor College of Medicine

First Received: April 8, 2003 Last Updated: December 20, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2014
Primary Completion Date:	February 2008 (Final data collection date for primary outcome measure)